Search - tctmd.com

Displaying 121 - 140 of 161

Sort: Relevancy | Date

Presentation

Triple Antithrombotic Therapy Is the Independent Predictor of Major Bleeding Complications

Presenter: Y. Naruse

August 26, 2013

News Daily News

El Cilostazol Adicional Reduce la Reestenosis en Pacientes de Alto Riesgo que recibieron un SLF

August 08, 2013

News Daily News

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

August 08, 2013

News Daily News

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

Caitlin E. Cox

June 20, 2013

Presentation TVT 2013

Is Triple Therapy a Triple Threat for Patients? DAPT and Chronic Anticoagulation

Presenter: Ted Feldman

June 15, 2013

News Daily News

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Caitlin E. Cox

April 19, 2013

Presentation Fellows 2013

Navigating the New Chronic Oral Anticoagulants and How to Deal with Triple Therapy

Presenter: Manesh Patel

April 16, 2013

News Daily News

Prasugrel Reloading Feasible After Clopidogrel Pretreatment in ACS Patients

Yael L. Maxwell

January 13, 2013

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2012

Caitlin E. Cox

January 02, 2013

News Conference News TCT 2012

Aspirin, Cilostazol Combination Best After Angioplasty for Critical Limb Ischemia

November 01, 2012

News Conference News TCT 2012

Stroke Prevention Strategies Discussed

October 26, 2012

News Conference News TCT 2012

FAME 2: FFR-Guided PCI Cost Effective vs. Medical Therapy

October 24, 2012

Presentation TCT 2012

When Triple Therapy Is Needed: Warfarin, Dabigatran, Rivaroxaban, and Cilostazol Considerations

Presenter: Harvey White

October 22, 2012

News Daily News

Un Meta análisis estudia Nuevos Anticoagulantes + Terapia Doble en Pacientes que han sufrido un SCA

October 02, 2012

News Daily News

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

October 02, 2012

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

News Conference News ESC 2012

WOEST: Clopidogrel Alone Works Best for PCI Patients on Oral Anticoagulants

Yael L. Maxwell

August 28, 2012

News Daily News

No Safe Window for Triple Antithrombotic Therapy in High-Risk A-fib Patients

August 14, 2012

News Daily News

No hay una Ventana Segura para la Terapia Antitrombótica Triple en Pacientes con FA de Alto Riesgo

August 14, 2012

Presentation

Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in A-fib Patients Following MI and PCI

Presenter: M. Lamberts

August 10, 2012

Advertisement

Triple Antithrombotic Therapy Is the Independent Predictor of Major Bleeding Complications

El Cilostazol Adicional Reduce la Reestenosis en Pacientes de Alto Riesgo que recibieron un SLF

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

Is Triple Therapy a Triple Threat for Patients? DAPT and Chronic Anticoagulation

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Navigating the New Chronic Oral Anticoagulants and How to Deal with Triple Therapy

Prasugrel Reloading Feasible After Clopidogrel Pretreatment in ACS Patients

Year in Review: Physicians Highlight the Most Important Interventional News of 2012

Aspirin, Cilostazol Combination Best After Angioplasty for Critical Limb Ischemia

Stroke Prevention Strategies Discussed

FAME 2: FFR-Guided PCI Cost Effective vs. Medical Therapy

When Triple Therapy Is Needed: Warfarin, Dabigatran, Rivaroxaban, and Cilostazol Considerations

Un Meta análisis estudia Nuevos Anticoagulantes + Terapia Doble en Pacientes que han sufrido un SCA

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

WOEST: Clopidogrel Alone Works Best for PCI Patients on Oral Anticoagulants

No Safe Window for Triple Antithrombotic Therapy in High-Risk A-fib Patients

No hay una Ventana Segura para la Terapia Antitrombótica Triple en Pacientes con FA de Alto Riesgo

Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in A-fib Patients Following MI and PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content